ArticleCase reports in urology2020

Pathologic Complete Response to Neoadjuvant Nivolumab/Ipilimumab in a Patient with Metastatic Renal Cell Carcinoma.

Taylor C Peak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.